Delivery Order SPE2DR25D1104-SPE2DR26FK657
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,040.22. The delivery order, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a non-competitive, competitively awarded procurement supporting federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $1,562.88. This is a firm fixed-price delivery order with an ultimate completion date of December 11, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was awarded on a non-set-aside, competitive basis, reflecting the contractor's established capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (quantity 100) on December 10, 2025, with a ceiling value of $8,511.54. This firm fixed-price delivery order is scheduled for ultimate completion on December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100 count) under a firm fixed-price contract with a ceiling value of $1,636.32. The order was competitively awarded without set-aside status and has an ultimate completion date of December 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and supply this pharmaceutical product to support federal...
- The Defense Logistics Agency has awarded a delivery order valued at $7,498.79 to AmerisourceBergen Drug Corp for the supply of Progesterone 100 mg capsules (100-count units). This firm fixed-price delivery order, awarded on December 8, 2025, with completion scheduled for December 9, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100 count) on October 16, 2025, with a ceiling value of $1,430.24 and ultimate completion date of October 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Progesterone 100 mg capsules (100-count unit) with a contract value of $3,889.37. This is a firm fixed-price delivery order issued without a set-aside designation, indicating competitive award to the vendor based on capability and pricing. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $1,152.00 delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count) on July 30, 2025, with a completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00...
- The Defense Logistics Agency awarded a $2,868.75 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Progesterone 100 mg capsules (100-count units). This firm fixed-price delivery order, with an ultimate completion date of December 16, 2025, was awarded without set-aside restrictions through competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $3,227.38. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by November 21, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK657Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,113.59 to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count) on December 15, 2025, with completion expected by December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad spectrum of medications and medical products to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. The company's federal portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains through firm fixed-price delivery orders of varying sizes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/14/25 |